
Articles
-
2 weeks ago |
chemistryworld.com | Anthony J. King
Initial agreements with China and UK have paused trade war, but uncertainty reigns Source: © CFOTO/Future Publishing/Getty Images The Trump administration in the US has sketched out a trade deal with China that reduces tariffs on both sides. This follows on from a general agreement with the UK on trade on 8 May. Full details have yet to be negotiated but industry has seen a reprieve from some sky-high tariffs.
-
1 month ago |
chemistryworld.com | Anthony J. King
The spotlight was recently shone on the work culture of Chinese universities earlier this year following the death of a professor of materials science, aged 47, at Zhejiang University. The family blamed an ‘insane’ workload for the death of Liu Yongfeng from cerebral haemorrhage, according to the South China Morning Post. An open letter posted online by his wife calculated his working hours between March 2024 and 20 January this year.
-
2 months ago |
chemistryworld.com | Anthony J. King
Decision ends pharmacies’ permission to prepare versions of GLP-1 hormone mimicsNovo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US, according to the US Food and Drug Administration (FDA). That means that compounding pharmacies and outsourcing facilities that had been legitimately preparing their own versions of the drugs will no longer be permitted to do so.
-
Mar 5, 2025 |
nature.com | Anthony J. King
It is tough for a person to find out that they have a progressive disease, especially when it threatens to rob them of their independence. With age-related macular degeneration (AMD) — the leading cause of vision loss among older people — a person faces a gradual and irreversible loss of vision, until they might no longer be able to recognize even a loved one.
-
Feb 27, 2025 |
nature.com | Anthony J. King
Drug discovery is extraordinarily difficult. “In 100 years or so of contemporary medicine, we’ve found treatments for only around 500 of the roughly 7,000 rare diseases,” says David Pardoe, a computational chemist at Evotec, a biotechnology company in Hamburg, Germany. “It takes too long and costs too much.” But in theory, and to the excitement of many, artificial intelligence (AI) could address both of these problems.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 713
- Tweets
- 431
- DMs Open
- Yes

RT @ChemistryWorld: ‘This study is a stark reminder of just how prevalent toxic chemicals are in the environment and the damaging impact th…

RT @ChemistryWorld: For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration. Vert…

RT @ChemistryWorld: Swiss researchers monitored cell growth and quantified changes in 2269 putative metabolites produced by lung cancer cel…